Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for cancer-related fatigue
IRCT20090613002027N12Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bupropion in cancer-related fatigue (CRF) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Degree of fatigue, Depression and 3 more. Started Apr 2018; status: completed.
02
Drugs
bupropion
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on IRCT20090613002027N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090613002027N12.